A novel Nrf2 pathway inhibitor sensitizes Keap1-mutant lung cancer cells to chemotherapy. Zhang D, Hou Z, Aldrich KE, Lockwood L, et al. Mol Cancer Ther 2021 Jun 22. pii: 1535-7163.MCT-21-0210.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zhang D, Hou Z, Aldrich KE, Lockwood L, et al. A novel Nrf2 pathway inhibitor sensitizes Keap1-mutant lung cancer cells to chemotherapy. Mol Cancer Ther 2021 Jun 22. pii: 1535-7163.MCT-21-0210.
PMID: 34158350